Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-12-31 4:18 pm Purchase | 2024-12-29 | 13D | Kala Pharmaceuticals, Inc. KALA | BAKER BROS. ADVISORS LP | 1,201,894 19.700% | 310,559 (+34.84%) | Filing History |
| 2024-11-14 4:49 pm Purchase | 2024-09-30 | 13G | Kala Pharmaceuticals, Inc. KALA | ADAR1 Capital Management LLC | 480,431 9.990% | 480,431 (New Position) | Filing History |
| 2024-07-08 8:54 pm Purchase | 2024-06-28 | 13D | Kala Pharmaceuticals, Inc. KALA | SR ONE CAPITAL MANAGEMENT LLC | 445,643 9.990% | 445,643 (New Position) | Filing History |
| 2024-06-28 4:11 pm Purchase | 2024-06-26 | 13D | Kala Pharmaceuticals, Inc. KALA | BAKER BROS. ADVISORS LP | 891,335 19.990% | 622,122 (+231.09%) | Filing History |
| 2024-02-16 4:11 pm Purchase | 2024-02-09 | 13G | Kala Pharmaceuticals, Inc. KALA | Millennium Management LLC | 135,096 5.000% | 135,096 (New Position) | Filing History |
| 2024-02-14 4:21 pm Purchase | 2023-12-31 | 13G | Kala Pharmaceuticals, Inc. KALA | BAKER BROS. ADVISORS LP | 269,213 9.990% | 88,300 (+48.81%) | Filing History |
| 2024-02-14 1:09 pm Sale | 2023-12-31 | 13G | Kala Pharmaceuticals, Inc. KALA | Checkpoint Capital L.P. | 0 0.000% | -228,032 (Position Closed) | Filing History |
| 2024-01-29 4:36 pm Sale | 2023-12-31 | 13G | Kala Pharmaceuticals, Inc. KALA | Integrated Core Strategies (US) LLC | 132,674 4.900% | -1,029 (-0.77%) | Filing History |
| 2023-10-18 4:04 pm Unchanged | 2023-05-01 | 13D | Kala Pharmaceuticals, Inc. KALA | Longitude Capital Partners II LLC | 108,239 4.300% | 0 (Unchanged) | Filing History |
| 2023-06-15 11:57 am Purchase | 2023-06-05 | 13G | Kala Pharmaceuticals, Inc. KALA | Checkpoint Capital L.P. | 228,032 9.700% | 228,032 (New Position) | Filing History |
| 2023-02-14 4:15 pm Sale | 2022-12-31 | 13D | Kala Pharmaceuticals, Inc. KALA | Longitude Capital Partners II LLC | 108,239 6.300% | -110,042 (-50.41%) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | Kala Pharmaceuticals, Inc. KALA | BAKER BROS. ADVISORS LP | 180,913 9.990% | 180,913 (New Position) | Filing History |
| 2023-01-17 4:38 pm Purchase | 2023-01-04 | 13G | Kala Pharmaceuticals, Inc. KALA | Integrated Core Strategies (US) LLC | 133,703 8.400% | 133,703 (New Position) | Filing History |
| 2022-06-03 5:11 pm Sale | 2022-06-02 | 13D | Kala Pharmaceuticals, Inc. KALA | RA CAPITAL MANAGEMENT L.P. | 136,515 4.700% | -111,277 (-44.91%) | Filing History |
| 2022-05-31 5:31 pm Sale | 2022-05-26 | 13D | Kala Pharmaceuticals, Inc. KALA | RA CAPITAL MANAGEMENT L.P. | 247,792 8.530% | -74,020 (-23.00%) | Filing History |
| 2022-05-25 5:12 pm Sale | 2022-05-23 | 13D | Kala Pharmaceuticals, Inc. KALA | RA CAPITAL MANAGEMENT L.P. | 321,812 11.080% | -114,773 (-26.29%) | Filing History |
| 2022-04-01 4:30 pm Sale | 2022-03-30 | 13D | Kala Pharmaceuticals, Inc. KALA | RA CAPITAL MANAGEMENT L.P. | 436,585 15.030% | -1,877 (-0.43%) | Filing History |
| 2022-02-14 11:50 am Sale | 2021-12-31 | 13G | Kala Pharmaceuticals, Inc. KALA | Eventide Asset Management, LLC | 0 0.000% | -138,000 (Position Closed) | Filing History |
| 2022-01-10 12:54 pm Sale | 2021-12-31 | 13G | Kala Pharmaceuticals, Inc. KALA | BlackRock Inc. BLK | 125,391 4.800% | -1,029 (-0.81%) | Filing History |
| 2021-11-26 4:17 pm Purchase | 2021-11-15 | 13D | Kala Pharmaceuticals, Inc. KALA | Lagunita LLC | 213,645 7.300% | 213,645 (New Position) | Filing History |